register

News & Trends - MedTech & Diagnostics

Lifting ban on non-essential elective surgery

Health Industry Hub | April 20, 2020 |

MedTech News: The Australian and New Zealand College of Anaesthetists (ANZCA) and the Royal Australasian College of Surgeons (RACS) have cautiously welcomed the Australian Government’s decision to consider the graded resumption of some types of recently cancelled elective surgery.

ANZCA President Dr Rod Mitchell said the safety of patients, healthcare workers and the community at large was paramount to ensure that they would not be at risk of infection with coronavirus.

“The SARS-CoV-2 pandemic remains a very significant threat to our community, and any changes to our elective surgery policy need to be made with extreme care.

We do recognise the adverse health effects on our patients by delaying elective surgery, so we need to weigh up the risks of postponing important surgery with the risks of recommencing it too quickly.

We need to make sure we take all steps to avoid increases in infection rates and to ensure our hospitals maintain adequate bed and intensive care capacity to care for people who do fall ill with the COVID 19 infection. This also ensures we do not use significant amounts of our personal protective equipment (PPE) unnecessarily, as these remain in relatively short supply.

Register FREE and join 20,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

We also need to maintain our social distancing measures within hospitals as far as possible, as this remains the most important factor in protecting our community.”

The Colleges said that rates of community transmission and PPE use will need to be closely monitored, and if these are adversely affected, we will need to be prepared to immediately cease all non-urgent elective surgery again.

RACS President Tony Sparnon said that a graduated introduction and strict observance of guidelines that considers regional circumstances would be appropriate and cautioned that this process could take at least two weeks to prevent an outbreak of infection.

“The resumption of elective surgery should be to help patients who are suffering or unable to function as normal. The safety of patients must be paramount so these should be patients who are at low risk of contracting coronavirus. We don’t want patients who require post-operative care to be operated on as this will put pressure on high dependency and intensive care units, however day procedures should be appropriate.”

Australia’s Chief Medical Officer Professor Brendan Murphy said authorities are looking into whether restarting non-essential elective surgery is viable in the short-term. “It is very important if we restart elective activity that we only do it through the confines of our available PPE supplies so it would be gentle, and it would have to ensure we have enough protective equipment,” he said. “That modelling is being done at the moment.”

The RACS President also urged governments to ensure that surgical associations are consulted regarding types of surgery.

“Our surgical associations will be critical in helping to determine what sort of surgery should be undertaken to ensure patient safety and proper use of equipment, including PPE.”

You may also like Role of MSLs in a COVID-19 world – survey results


News & Trends - Pharmaceuticals

March PBAC agenda unveiled amid tensions over 'unprecedented' volume of submissions

March PBAC agenda unveiled amid tensions over ‘unprecedented’ volume of submissions

Health Industry Hub | November 29, 2024 |

The Department of Health has released the agenda for the March 2025 Pharmaceutical Benefits Advisory Committee (PBAC) meeting, unveiling plans […]

More


News & Trends - MedTech & Diagnostics

Johnson & Johnson MedTech exits DePuy Synthes spine portfolio

J&J MedTech exits DePuy Synthes spine portfolio

Health Industry Hub | November 29, 2024 |

Johnson & Johnson MedTech will officially exit the DePuy Synthes Spine portfolio in Australia tomorrow, November 30, as part of […]

More


News & Trends - Pharmaceuticals

Home-grown hypertension polypill heads for regulatory approval

Home-grown hypertension polypill heads to regulatory approval

Health Industry Hub | November 29, 2024 |

Australian-supported research has revealed remarkable Phase III clinical trial results for an innovative triple drug combination in the treatment of […]

More


News & Trends - Pharmaceuticals

Will Australia become first country to eliminate HIV transmission by 2030?

Will Australia become first country to eliminate HIV transmission by 2030?

Health Industry Hub | November 29, 2024 |

In the lead-up to World AIDS Day on December 1, the Albanese Government has unveiled the 9th National HIV Strategy, […]

More


This content is copyright protected. Please subscribe to gain access.